ERBB2 and obesity due to melanocortin 4 receptor deficiency: On the other hand, in a study by Modi and colleagues involving patients with metastatic HER2-positive breast cancer, elevated BMI was associated with improved PFS and OS, supporting the presence of an obesity paradox in the advanced disease setting [13].